Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

Glimepiride (Amaryl) and Weight Gain

Share Post:

What is Glimepiride (Amaryl)?

Glimepiride, also known by its brand name Amaryl, is an oral prescription drug that is used together with exercise and treatment program to control the level of blood glucose in patients with type 2 diabetes. Glimepiride belong to a class of medications called sulfonylureas which act by stimulating the beta cells to produce more insulin. Hence, Amaryl cannot be used in patients with type 1 diabetes because it requires the beta cells to function normally. This medicine may be used alone or in combination with insulin or oral diabetes drugs to control blood sugar in type 2 diabetic patients.

Glimepiride and weight gain

Like most diabetes drugs, sulfonylureas such as glimepiride are known to cause weight gain in patients. Studies have associated glimepiride to weight gain. In one study patients were put under placebo and amaryl treatment over a period of 14 weeks. Patients were randomized to take tablets of 1mg, 4mg, and 8mg. Compared to patients under placebo treatment, those who took higher doses of amaryl tablets showed an increase in weight. On average, patients who took 1mg of this medication gained 2kg more than those in placebo group, while those who took 4mg and 8mg of amaryl gained 2.8 and 3.2kg respectively. The study concluded that a once daily dose of amaryl was effective in controlling blood sugar levels.

Doctor’s Recommendation

Glimepiride is less likely to cause hypoglycemia and has a much less significant effect on weight gain than other sulfonylureas; therefore, these are reasonable medicines for additional sugar control when Metformin is insufficient.


Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.

Medically Reviewed

Profile image of Dr Pawel Zawadzki

Medically Reviewed By Dr Pawel ZawadzkiDr. Pawel Zawadzki, a U.S.-licensed MD from McMaster University and Poznan Medical School, specializes in family medicine, advocates for healthy living, and enjoys outdoor activities, reflecting his holistic approach to health.

Profile image of CDI Staff Writer

Written by CDI Staff WriterOur internal team are experts in many subjects. on March 4, 2022

Related Products

Promotion
Ozempic
  • In Stock
  • Express Shipping
Promotion
Mounjaro Vial
  • In Stock
  • Express Shipping
Promotion
Rybelsus
  • In Stock
  • Express Shipping
Bulk Savings
Humalog Vial
  • In Stock
  • Express Shipping

Related Articles

Cardiovascular Health, Diabetes,
Mounjaro Heart Benefits That Go Beyond Weight Loss

Weight loss often steals the spotlight when people talk about Mounjaro, but the story doesn’t end there. Did you know that cardiovascular disease remains the leading cause of death for…

Read More
Weight Loss
Ozempic Rebound: How to Prevent Weight Regain

Weight loss with medications like Ozempic has become a life-changing experience for many. People who struggled for years to lose weight are finally seeing results: lower numbers on the scale,…

Read More
Weight Loss
How GLP-1 Weight Loss Drugs Are Lowering Obesity Rates

The tide may be turning on obesity in the U.S.—Gallup finds adult rates have dipped to 37% from 39.9% three years ago, and experts attribute much of this shift to…

Read More
General Health, Weight
How to Travel with Zepbound on Flights and Vacations

Traveling while on medication requires a little extra planning, especially when that medication is temperature-sensitive, like Zepbound. Many adults with chronic conditions travel each year, and maintaining consistent treatment while…

Read More